Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Medimmune Inc /de (MEDI) since 2006 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Medimmune Inc /de. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 873591.
Total stock buying since 2006: $0.
Total stock sales since 2006: $6,085,361.
Total stock option exercises since 2006: $4,571,265.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2007 | 0 | $0 | 76,463 | $2,374,276 | 361,482 | $2,304,316 |
2006 | 0 | $0 | 112,202 | $3,711,085 | 291,668 | $2,266,949 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2007-03 | 0 | $0 | 0 | $0 | 286,482 | $2,119,966 |
2007-02 | 0 | $0 | 76,463 | $2,374,276 | 75,000 | $184,350 |
2006-12 | 0 | $0 | 0 | $0 | 109,326 | $268,723 |
2006-05 | 0 | $0 | 0 | $0 | 30,000 | $84,990 |
2006-03 | 0 | $0 | 0 | $0 | 16,140 | $44,385 |
2006-02 | 0 | $0 | 112,202 | $3,711,085 | 136,202 | $1,868,851 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-03-23 | Mott David M (Vice Chairman, CEO & President) | Option Ex | 129,389 | 7.40 | 957,478 |
2007-03-21 | Mott David M (Vice Chairman, CEO & President) | Option Ex | 53,593 | 7.40 | 396,588 |
2007-03-19 | Mott David M (Vice Chairman, CEO & President) | Option Ex | 103,500 | 7.40 | 765,900 |
2007-02-13 | Zoth Lota S (Senior Vice President & CFO) | Sale | 1,463 | 31.38 | 45,901 |
2007-02-08 | Connor Edward M (Executive Vice President, CMO) | Sale | 75,000 | 31.05 | 2,328,375 |
2007-02-08 | Connor Edward M (Executive Vice President, CMO) | Option Ex | 75,000 | 2.46 | 184,350 |
2006-12-06 | Mott David M (Vice Chairman, CEO & President) | Option Ex | 109,326 | 2.46 | 268,723 |
2006-05-01 | Macklin Gordon S (Director) | Option Ex | 30,000 | 2.83 | 84,990 |
2006-03-08 | Mott David M (Vice Chairman, CEO & President) | Option Ex | 16,140 | 2.75 | 44,385 |
2006-02-15 | Connor Edward M (EVP, Clinical Dev., CMO) | Option Ex | 24,000 | 2.75 | 66,000 |
2006-02-08 | Kiener Peter A (SVP, Research) | Sale | 12,000 | 33.41 | 400,955 |
2006-02-08 | Kiener Peter A (SVP, Research) | Option Ex | 12,000 | 23.45 | 281,400 |
2006-02-07 | Hackman Franklin Barbara (Director) | Sale | 40,000 | 33.68 | 1,347,040 |
2006-02-07 | Hackman Franklin Barbara (Director) | Option Ex | 40,000 | 6.75 | 270,000 |
2006-02-03 | Mathers Edward T (SVP, Corporate Dev.) | Sale | 40,000 | 32.59 | 1,303,440 |
2006-02-03 | Mathers Edward T (SVP, Corporate Dev.) | Option Ex | 40,000 | 23.81 | 952,400 |
2006-02-03 | Anido Armando (EVP, Sales and Mktg) | Sale | 11,562 | 32.67 | 377,788 |
2006-02-03 | Anido Armando (EVP, Sales and Mktg) | Option Ex | 11,562 | 23.81 | 275,291 |
2006-02-03 | Young James F (President, R&D) | Sale | 8,640 | 32.62 | 281,862 |
2006-02-03 | Young James F (President, R&D) | Option Ex | 8,640 | 2.75 | 23,760 |
Insider trading activities including stock purchases, stock sales, and option exercises of MEDI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Medimmune Inc /de (symbol MEDI, CIK number 873591) see the Securities and Exchange Commission (SEC) website.